EIAV vector-mediated delivery of endostatin or angiostatin inhibits angiogenesis and vascular hyperpermeability in experimental CNV.

Source:http://linkedlifedata.com/resource/pubmed/id/16572190

Download in:

View as

General Info

PMID
16572190